This paper was presented on day 1 of the ERA Congress 2022 on May 19th 2022 by Drs. Marion Pepin,
This paper was presented on day 1 of the ERA th Congress 2022 on May 19 2022 by Drs. Bilge
End stage renal disease (ESRD) is chronic inflammatory condition which affects iron parameters. Serum soluble transferrin receptor (sTfR) is a
Recent studies suggest the possibility of activating immune mechanism in the onset and progression of atherosclerotic disease. The aim of
The reliability of haemoglobin A1c (HbA1c) as a glycaemic marker in patients receiving haemodialysis (HD) remains unknown. To assess accuracy,
Post-transplant hypercalcemia is common after successful kidney transplantation in patients with chronic kidney disease (CKD) and can be partially explained
IgA nephropathy (IgAN) is the most common primary glomerulonephritis globally and an important cause of chronic kidney disease (CKD). Up
Dapagliflozin is an inhibitor of sodiumdependent glucose transporters 2, which is a new drug for diabetes mellitus. Recent researches indicated
Chronic kidney disease (CKD) continues to be a growing health concern worldwide, with an estimated global prevalence of 9.1% in
Sodium-glucose co-transporter 2 (SGLT2) inhibitors, the most recent glucose lowering oral agents, prevent glucose and sodium reabsorption at proximal tubules.